DJIA 18,080.14 21.45 0.12%
NASDAQ 5,092.09 36.02 0.71%
S&P 500 2,117.69 4.76 0.23%
market minute promo

25.42 -0.52 (-2.00%)

REAL-TIME: Last trade at

company name or ticker

Recent Quotes

AEGR $25.42 -2.00%
1D 1W 3M 6M 1Y 2Y 3Y
Today's Open $26.05
Previous Close $25.94
Daily Range $25.40 - $26.15
52-Week Range $19.10 - $45.92
Market Cap $725.5M
P/E Ratio -19.21
Dividend (Yield) $0.00 (0.0%)
Volume 297,571
Average Daily Volume 455,665
Current FY EPS -$1.48




Drug Makers

Aegerion Pharmaceuticals, Inc. (AEGR) Description

Aegerion Pharmaceuticals, Inc. Website:

News & Commentary Rss Feed

Is This The Biggest Threat to Isis Pharmaceuticals Stock?

Isis Pharmaceuticals has garnered a massive premium based on the potential of its antisense drug pipeline. With numerous companies entering the rare disease field, though, Isis' drugs might face stiff competition. So are investors being overly optimistic?

Why It’s Not Too Late to Buy Isis Pharmaceuticals Stock

Isis Pharmaceuticals has had an enormous run of late. Is this drugmaker still a buy?

Aegerion Pharmaceuticals Expects Little Growth In 2015

Aegerion's Q4 Loss Narrows Y/Y, Ups Juxtapid Sales View - Analyst Blog

Aegerion Pharmaceuticals' (AEGR) CEO Marc Beer on Q4 2014 Results - Earnings Call Transcript

Aegerion Pharmaceuticals (AEGR) Q4 2014 Results - Earnings Call Webcast

Will Aegerion (AEGR) Miss Earnings Estimates This Season? - Analyst Blog

Next Week In Biotech: Arena And Vivus Report, Radiesse And Avedro Ad Comms

Buying This Biotech Is Like Purchasing a Lottery Ticket

Our Motley Fool contributors think these three stocks could have the same risks of a lottery ticket.

Activist Discloses 5.7% Stake In Aegerion Pharmaceuticals

See More AEGR News...

AEGR's Top Competitors

AEGR $25.42 (-2.00%)
Current stock: AEGR
JNJ $101.08 (0.62%)
Current stock: JNJ
NVS $104.28 (-1.16%)
Current stock: NVS
RHHBY $36.24 (-0.83%)
Current stock: RHHBY